9 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
comorbidities or risk ... fluoroquinolone #IDSA ... Management #Guidelines #pharmacology
Debridement and Management of Prosthetic Joint Infection (PJI)
Duration of symptoms <3 weeks OR  <30 days
Joint Infection (PJI ... whether benefit > risk ... Cortes_Penfield #PJI
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... with epidemic risk ... patients are still at risk ... Trypanosomiasis #IDSA ... infections #HIVAIDS #pharmacology
Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
 • Triple therapy = increased bleeding
Therapy after PCI ... - Bleeding risk ... reduced bleeding risk ... anticoagulation #PCI ... #pharmacology #
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... issue and the risk ... #Cryptococcus #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... mm3 and at high risk ... Histoplasmosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... Pneumocystis #Pneumonia #IDSA ... Treatment #PCP #PJP ... HIVAIDS #management #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... viremia are strong risk ... KaposiSarcoma #Castlemans #IDSA ... infections #HIVAIDS #pharmacology
Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Adults
Initial empirical therapy: 
 • Amoxicillin-clavulanate (500 mg/125 mg
400 mg PO qd) Risk ... Antimicrobial #empiric #idsa ... Adults #management #pharmacology